Jelle Vriend

565 total citations
11 papers, 344 citations indexed

About

Jelle Vriend is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Jelle Vriend has authored 11 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Oncology. Recurrent topics in Jelle Vriend's work include Drug Transport and Resistance Mechanisms (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Renal and related cancers (3 papers). Jelle Vriend is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Renal and related cancers (3 papers). Jelle Vriend collaborates with scholars based in Netherlands, Switzerland and Canada. Jelle Vriend's co-authors include Martijn J. Wilmer, Rosalinde Masereeuw, Tom T.G. Nieskens, Henriëtte L. Lanz, Laura Suter‐Dick, Marianne K. Vormann, Frans G. M. Rüssel, Victor Samokhvalov, K. Lockhart Jamieson and Paul Vulto and has published in prestigious journals such as Biochimica et Biophysica Acta (BBA) - General Subjects, Frontiers in Pharmacology and Toxicology Letters.

In The Last Decade

Jelle Vriend

10 papers receiving 334 citations

Peers

Jelle Vriend

BE

MB

BIOCH

NEPHR

PFM

Zdeněk Tauber Czechia

Peng Zhu China

Mir Amir Aghdashi Iran

Hui Du China

Johnson H.Y. Yip Hong Kong

Ruan Cox United States

Megan T. Quintana United States

Shuai Jin China

Pauline Estèves France

Zdeněk Tauber Czechia

Jelle Vriend

22 ×0.1

BE

76 ×0.5

MB

25 ×0.4

BIOCH

4 ×0.1

NEPHR

6 ×0.1

PFM

Citations per year, relative to Jelle Vriend Jelle Vriend (= 1×) peers Zdeněk Tauber

Countries citing papers authored by Jelle Vriend

Since Specialization

Citations

This map shows the geographic impact of Jelle Vriend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jelle Vriend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jelle Vriend more than expected).

Fields of papers citing papers by Jelle Vriend

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jelle Vriend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jelle Vriend. The network helps show where Jelle Vriend may publish in the future.

Co-authorship network of co-authors of Jelle Vriend

This figure shows the co-authorship network connecting the top 25 collaborators of Jelle Vriend. A scholar is included among the top collaborators of Jelle Vriend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jelle Vriend. Jelle Vriend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Vriend, Jelle, et al.. (2024). Animal-free safety assessment of chemicals: an innovation system perspective. Archives of Toxicology. 99(1). 43–56. 6 indexed citations

2.

Vriend, Jelle, Marianne K. Vormann, Henriëtte L. Lanz, et al.. (2021). Nephroscreen: A robust and versatile renal tubule-on-a-chip platform for nephrotoxicity assessment. Current Opinion in Toxicology. 25. 42–48. 9 indexed citations

3.

Vriend, Jelle, et al.. (2020). In vitro models for accurate prediction of renal tubular xenobiotic transport in vivo. Current Opinion in Toxicology. 25. 15–22. 3 indexed citations

4.

Vriend, Jelle, Janny G.P. Peters, Tom T.G. Nieskens, et al.. (2019). Flow stimulates drug transport in a human kidney proximal tubule-on-a-chip independent of primary cilia. Biochimica et Biophysica Acta (BBA) - General Subjects. 1864(1). 129433–129433. 58 indexed citations

5.

Vriend, Jelle, Charlotte A. Hoogstraten, Bartholomeus T. van den Berge, et al.. (2019). Organic anion transporters 1 and 3 influence cellular energy metabolism in renal proximal tubule cells. Biological Chemistry. 400(10). 1347–1358. 16 indexed citations

6.

Vriend, Jelle, Tom T.G. Nieskens, Marianne K. Vormann, et al.. (2018). Screening of Drug-Transporter Interactions in a 3D Microfluidic Renal Proximal Tubule on a Chip. The AAPS Journal. 20(5). 87–87. 62 indexed citations

7.

Suter‐Dick, Laura, Marianne K. Vormann, Henriëtte L. Lanz, et al.. (2018). Combining Extracellular miRNA Determination with Microfluidic 3D Cell Cultures for the Assessment of Nephrotoxicity: a Proof of Concept Study. The AAPS Journal. 20(5). 86–86. 29 indexed citations

8.

Vormann, Marianne K., Linda Gijzen, L. M. Boot, et al.. (2018). Nephrotoxicity and Kidney Transport Assessment on 3D Perfused Proximal Tubules. The AAPS Journal. 20(5). 90–90. 96 indexed citations

9.

Wilmer, Martijn J., Jelle Vriend, Tom T.G. Nieskens, et al.. (2017). Renal toxicity biomarker analysis upon compound exposures in a kidney-on-a-chip. Toxicology Letters. 280. S140–S140.

10.

Samokhvalov, Victor, K. Lockhart Jamieson, Jelle Vriend, Song Quan, & John M. Seubert. (2015). CYP epoxygenase metabolites of docosahexaenoic acid protect HL-1 cardiac cells against LPS-induced cytotoxicity through SIRT1. Cell Death Discovery. 1(1). 31 indexed citations

11.

Samokhvalov, Victor, et al.. (2014). PPARÎ³ signaling is required for mediating EETs protective effects in neonatal cardiomyocytes exposed to LPS. Frontiers in Pharmacology. 5. 242–242. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact